---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000301"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T08:59:16.630604+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma enters ATM sales agreement for up to $60M in common stock

## Summary
- Agreement with A.G.P./Alliance Global Partners allows at-the-market sales of up to $60 million in common stock.
- Board initially reserved 171,428,571 shares based on $0.35 reference price; commission set at 3.0% of gross proceeds.
- Sales may occur from time to time via NYSE American; agent not obligated to purchase shares on principal basis.
- Annual maintenance fee of $10,000 payable to sales agent; agreement terminates after three years or earlier by notice.

## SEC filing metadata
- accession: 0001185185-24-000301
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000301/0001185185-24-000301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000301/igcpharma20240320c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000301
- JSON: https://secwatch.observer/filing/0001185185-24-000301.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000301.txt

## Key facts
- Material Agreements
  IGC Pharma, Inc. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at aggregate offering price subject to certain limitations on the amount of Common Stock that may be of (effective 2024-03-19).
  - Action: entry
  - Agreement: atm program
  - Counterparty: A.G.P./Alliance Global Partners
  - Value: aggregate offering price subject to certain limitations on the amount of Common Stock that may be of
  - Effective: 2024-03-19
  source text: On March 19, 2024, IGC Pharma, Inc. (the “Company”) entered into a new Sales Agreement (the “Agreement”) with A.G.P./Alliance Global Partners (the “Agent”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000301/0001185185-24-000301-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.